In 2002 Saito isolated from the fungus Ctenomyces serratus the novel KOR antagonist CJ-15,208 (1), c[Phe-pro-Phe-Trp], Ki = 29 nM. In 2009, Dolle synthesized the diastereoisomer c[Phe-pro-Phe-trp], nearly 8fold more active. These compounds exhibited no agonism in vitro, however Aldrich observed unexpected MOR agonism in vivo for 1 and derivatives. These compounds show pronounced similarity with c[Phe-Gly-Tyr-pro-trp] (2), Ki(MOR) = 34 nM synthesized by a completely different approach. The sequence Ac-trp-Phe-GlyNH2 still maintains nanomolar affinity, high MOR selectivity, and the agonist behavior. Apparently, the Trp-Phe sequence represent a pharmacoric motif for both 1 and 2.1 In this work we investigate the pharmacological profile and 3D structures of peptides containing overlapping portions of 1 and 2. This analysis led to the proposal of plausible bioactive conformations.
R. De Marco, E. Pirazzoli, L. Cavina, A. Tolomelli, A. Bedini, S. Spampinato, et al. (2013). Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations. European opiod Conference.
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations
DE MARCO, ROSSELLA;TOLOMELLI, ALESSANDRA;BEDINI, ANDREA;SPAMPINATO, SANTI MARIO;GENTILUCCI, LUCA
2013
Abstract
In 2002 Saito isolated from the fungus Ctenomyces serratus the novel KOR antagonist CJ-15,208 (1), c[Phe-pro-Phe-Trp], Ki = 29 nM. In 2009, Dolle synthesized the diastereoisomer c[Phe-pro-Phe-trp], nearly 8fold more active. These compounds exhibited no agonism in vitro, however Aldrich observed unexpected MOR agonism in vivo for 1 and derivatives. These compounds show pronounced similarity with c[Phe-Gly-Tyr-pro-trp] (2), Ki(MOR) = 34 nM synthesized by a completely different approach. The sequence Ac-trp-Phe-GlyNH2 still maintains nanomolar affinity, high MOR selectivity, and the agonist behavior. Apparently, the Trp-Phe sequence represent a pharmacoric motif for both 1 and 2.1 In this work we investigate the pharmacological profile and 3D structures of peptides containing overlapping portions of 1 and 2. This analysis led to the proposal of plausible bioactive conformations.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.